Editorial

  • HOME
  • ARTICLE CATEGORY
  • Editorial
Editorial
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Young-Joo Jin
Clin Mol Hepatol. 2023;29(2):414-416.   Published online February 28, 2023
View: 2432   Download: 48
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Byeong Geun Song, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(2):411-413.   Published online March 6, 2023
View: 632   Download: 24
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Ji-Won Park, Ki Tae Suk
Clin Mol Hepatol. 2023;29(2):408-410.   Published online March 16, 2023
View: 639   Download: 39
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
Clin Mol Hepatol. 2023;29(2):404-407.   Published online March 14, 2023
View: 765   Download: 32
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Kee-Huat Chuah, Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(2):401-403.   Published online February 28, 2023
View: 682   Download: 29
Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
Maamon Basheer, Mohamed Naffaa, Nimer Assy
Clin Mol Hepatol. 2023;29(2):398-400.   Published online February 13, 2023
View: 754   Download: 68
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Lynna Alnimer, Mazen Noureddin
Clin Mol Hepatol. 2023;29(2):394-397.   Published online April 1, 2023
View: 707   Download: 39
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Clin Mol Hepatol. 2023;29(2):390-393.   Published online March 20, 2023
View: 647   Download: 22
Implications of comorbidities in nonalcoholic fatty liver disease
Sherlot Juan Song, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2023;29(2):384-389.   Published online March 14, 2023
View: 802   Download: 45
Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
Ho Soo Chun, Minjong Lee
Clin Mol Hepatol. 2023;29(2):377-380.   Published online March 9, 2023
View: 662   Download: 40
The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
Clin Mol Hepatol. 2023;29(2):374-376.   Published online March 6, 2023
View: 625   Download: 30
Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Clin Mol Hepatol. 2023;29(2):367-370.   Published online March 20, 2023
View: 631   Download: 35
1795
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
Moon Haeng Hur, Jeong-Hoon Lee
Clin Mol Hepatol. 2023;29(2):363-366.   Published online March 9, 2023
View: 659   Download: 43
1802
The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2023;29(2):358-362.   Published online March 14, 2023
View: 757   Download: 30
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clin Mol Hepatol. 2023;29(2):355-357.   Published online March 9, 2023
View: 667   Download: 27
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Shen-Yung Wang
Clin Mol Hepatol. 2023;29(2):349-351.   Published online March 20, 2023
View: 746   Download: 28
The prime time for management of hepatocellular carcinoma in Hong Kong
Landon L. Chan, Stephen L. Chan
Clin Mol Hepatol. 2023;29(2):345-348.   Published online March 9, 2023
View: 681   Download: 29
Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
Clin Mol Hepatol. 2023;29(2):342-344.   Published online March 16, 2023
View: 744   Download: 32
The clinical management of hepatocellular carcinoma in China: Progress and challenges
Shan Shan, Jidong Jia
Clin Mol Hepatol. 2023;29(2):339-341.   Published online March 16, 2023
View: 738   Download: 37
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Do Young Kim
Clin Mol Hepatol. 2023;29(2):335-338.   Published online March 20, 2023
View: 693   Download: 28
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clin Mol Hepatol. 2023;29(2):332-334.   Published online March 16, 2023
View: 655   Download: 21
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Lilian Yan Liang, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
Clin Mol Hepatol. 2023;29(1):113-117.   Published online October 31, 2022
View: 1521   Download: 72  Citations: 2
Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Susana G Rodrigues
Clin Mol Hepatol. 2023;29(1):110-112.   Published online December 12, 2022
View: 1535   Download: 64
1730
Non-invasive tests-based risk stratification: Baveno VII and beyond
Georg Semmler, Mathias Jachs, Mattias Mandorfer
Clin Mol Hepatol. 2023;29(1):105-109.   Published online November 23, 2022
View: 1667   Download: 70  Citations: 2
The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
Jeong-Ju Yoo, Sang Gyune Kim
Clin Mol Hepatol. 2023;29(1):102-104.   Published online November 10, 2022
View: 1410   Download: 96  Citation: 1
The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(1):99-101.   Published online October 27, 2022
View: 1515   Download: 59

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 285
TOTAL : 1298972
Close layer